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Live donation benefits recipients, but the long-term
consequences for donors remain uncertain. Renal and
Lung Living Donors Evaluation Study surveyed kidney
donors (N¼ 2455; 61% women; mean age 58, aged 24–
94; mean time from donation 17 years, range 5–48
years) using the Short Form-36 Health Survey (SF-36).
The 95% confidence intervals for White and African-
American donors included or exceeded SF-36 norms.
Over 80% of donors reported average or above average
health for their age and sex (p< 0.0001). Donors’ age–
sex adjusted physical component summary (PCS)
scores declined by half a point each decade after
donation (p¼ 0.0027); there was no decline in mental
component summary (MCS) scores.White donors’ PCS
scores were three points higher (p¼ 0.0004) than non-
Whites’; this difference remained constant over time.
Nine percent of donors had impaired health (PCS or
MCS score >1 SD below norm). Obesity, history of
psychiatric difficulties and non-White race were risk
factors for impaired physical health; history of psychi-
atric difficulties was a risk factor for impaired mental
health. Education, older donation age and a first-
degree relation to the recipientwere protective factors.
One percent reported that donation affected their
health very negatively. Enhanced predonation evalua-
tion and counseling may be warranted, along with
ongoing monitoring for overweight donors.
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Introduction
The benefits of living kidney donation to the recipient are
well-established (1–2), but uncertainty remains regarding
the long-term impacts on living donors (3). Studies have
confirmed that surgical complication rates are low, and
serious psychiatric sequelae are rare (4–6). Reports suggest
that the majority of living donors experience levels of
health-related quality of life (HRQOL) similar to or exceed-
ing that of the general population (7–9). Nevertheless, it has
been consistently shown that some donors (<5%) experi-
ence significant psychological distress or retain highly
negative attitudes about donation (10,11). Information on
the predictors and correlates of poor HRQOL outcomes is
extremely limited (5), particularly for minority donors or the
growing number of overweight donors (3,6,12–14).
TheRenal andLungLivingDonorsEvaluationStudy (RELIVE)
provided a unique opportunity to investigate the long-term
HRQOL of living donors. RELIVE conducted an extensive
chart review to identify all living donor surgeries performed
from 1963 to 2005 at three large US transplant centers (15).
Where possible, donor current address and phone contact
information were derived from these records, and surviving
donors requested to complete HRQOL questionnaires. The
Short Form-36 Health Survey (SF-36) health survey (16) was
included in this questionnaire because it is a standardized
instrument with norms for US adults overall and grouped by
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age and sex. SF-36 results from theAfrican-AmericanHealth
Project (AAHP) (17) provided nondonor comparison data for
African-American donors. The study objectives were to
provide a comprehensive analysis of the HRQOL of a large
and representative sample of living kidney donors, and to
identify predictors of poor long-term HRQOL outcomes.We
hypothesized that donors’ current HRQOL would be influ-
enced by factors known at the time of donation, and also
influenced byperceptions regarding the donationexperience
such as expected recovery time, time to resumption of usual
activities and comfort with decision to donate, among other
factors.
Methods
The RELIVE study was designed to evaluate the medical and HRQOL
outcomes of living kidney donors at three large US transplant centers.
Details about RELIVE have been published elsewhere (15).
Study design and population
An observational, cross-sectional survey of living kidney donors at least
5 years from time of donation was conducted. Enrollment is detailed in
Figure 1. Medical records from all living kidney donor surgeries conducted at
the three study sites (N¼ 8951) were reviewed. Surgeries performed after
July 1, 2005 and known deaths were excluded, leaving 6909 potentially
eligible donors (donation years 1963–2005). A study invitation letter was
sent to each donor. If no response was received, a follow-up letter and at
least two telephone calls were made by study coordinators. Although a fee-
based Internet service was used to update address and phone numbers,
current address and phone information could not be found for 13.6%
(n¼ 938). Thirty-six percent overall (n¼ 2501) did not respond to any study
contact attempts. This varied by race: 34% ofWhite donors, 58% of African-
American donors and 27% of donors of other or unknown race did not
respond to any study contacts (Table S1). The true status of these donors is
unknown; it is likely that somewere passive refusals and others were never
contacted. Fifty percent (n¼ 3470) of the potentially eligible donors were
contacted: 2455 consented and completed a study questionnaire; 931
refused consent; 79 consented but failed to return the questionnaire and five
were unable to participate due to a language barrier. Among those
 
 
Medical records assessed for eligibility (n=8951) 
Mayo=2341, UAB=2912, UMN=3698 
Excluded by record review (n=2042)  
♦ Donated after 6/30/2005 and/or believed to 
be deceased  
Unsuccessful contact attempts (n=3439) 
♦ No current address/phone (n=938) 
♦ Mailed/phoned with no response (n=2501)  
Did not participate (n=79) 
♦ Withdrew consent (n=24) 
♦ Did not return QOL questionnaire (n=55) 
Consented (n=2534) 
Mayo=793, UAB=546, UMN=1195 
Returned QOL questionnaire (n=2455) 
Eligible for QOL questionnaire (n=6909) 
Contacted (n=3470)
Did not provide consent (n=936) 
♦ Refused consent (n=931) 
♦ Language barrier (n=5) 
Figure 1: Enrollment flow diagram. This diagram describes how the sample of living organ donors who completed quality-of-life (QOL)
questionnaires for this study (N¼2455)was derived from a comprehensive review of themedical records of all live donor kidney transplants
conducted at three large clinical sites: University of Minnesota (UMN); The Mayo Clinic—Rochester, MN and University of Alabama,
Birmingham (UAB).
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contacted, rates of questionnaire completion were similar across transplant
centers (67–76%) and for White and African-American donors (71% and
72%, respectively), and somewhat lower (65%) for donors of other or
unknown race (Table S1). Participation rates diminishedwith increasing time
from donor surgery, from 79% for procedures done since January 2000 to
55% for those done in the 1960s.
This study was approved by the institutional review boards of the transplant
(UAB: IRB approval number X070604010; UMN: IRB approval number
0905M66501; Mayo: IRB approval number 09-001345) and data coordinat-
ing centers (IRB approval number CR00032674 and protocol number
HUM00004345). Informed consent was given by each participant.
Data collection
HRQOL questionnaires were mailed, self-administered and returned in
postage-paid envelopes. Questionnaires included the SF-36, version
2 (16,18), a self-assessment of day-to-day function and well-being over
the previous 4 weeks in eight domains of HRQOL. Domain scores are
standardized to the age and sex distribution of the US adult population and
combined to form physical andmental component summary (PCS andMCS)
scores. Higher scores indicate better health. SF-36 results were compared
to the National Health Measurement Survey (NHMS) (19). Table S2 provides
additional details about scoring and interpreting the SF-36.
Statistical analyses
Differences between respondents and nonrespondents by demographic
characteristics, and differences among donors grouped by race, were
examined using chi-square or Fisher’s exact tests and one-way analyses of
variance or rank tests for categorical and continuous predictors, respectively.
Donors’ SF-36 scores were compared to norms and other samples using t-
tests and rank tests. Quantile regression estimated the impact of race,
procedure (laparoscopic or open) and time from donation on sex-by-age
adjusted PCS and MCS scores. Multivariable logistic regression analyses
identified factors that predicted a poor HRQOL outcome. Factors known
prior to the time of donation surgery were used to fit an initial prediction
model using a best subsets approach. Additional models tested whether
donation experience variables were associated with poor HRQOL, after
adjustment for the initial model. Missing data were imputed using
IVEware (20) and analyses were conducted using SAS 9.2 (SAS Institute,
Cary, NC). See the online supplement for statistical methodology details. A
meaningful difference was defined as three points on the SF-36 MCS or
PCS. Statistical significancewas determined using a threshold of p< 0.01 to
control Type I error and to focus on results where differences were most
likely to be both statistically significant and clinically meaningful.
Results
RELIVE donors (n¼ 2455) were 15–74 years old at time of
donation and 24–94 years old at time of study. The mean
age at donation was 41 years, and women outnumbered
men (61%). On average, 17 10 years had elapsed since
donation surgery. The majority of donors were White
(93%), married (75%), educated beyond high school (77%)
and working full (52%) or part-time (12%) (Table 1). Most
were biologically related to their recipient as a sibling (41%),
parent (18%) or child (13%). Nine percent were spouses.
Seven percent were a friend of the recipient, and 6%were
not a relative or friend of the recipient. Five percent of
donors identified themselves as Black or African-American
(n¼113), and 1% as Hispanic or Latino (n¼31). White
donors were older than African-American donors, and were
more likely to be currently married. Weight at time of
donation, measured by body mass index (BMI), did not
differ by race.
Compared to donors who declined study participation,
RELIVE donors were slightly younger at donation (mean
ages 40.5 vs. 41.5), donated more recently (16.3 vs. 19.5
years), had higher educational attainment at time of
donation (56% vs. 39% educated beyond high school),
and were more likely to be unrelated to their recipient (13%
vs. 6%, all p<0.01) (see Table S1).
To investigate the representativeness of our sample, we
compared the demographics of RELIVE donors to 2009 US
kidney donors, using data published in the OPTN/SRTR
2010 Annual Report (see Table S3). Although the mean age
at donation was very close (about 41 years) and the percent
of women (61%) was the same, substantially fewer
RELIVE donors were African-American (5% vs. 12%) or
Hispanic/Latino (1% vs. 14%) compared to the 2009 US
donor data. Moreover, most of the African-American
RELIVE donors (81%) had donated at a single site: the
University of Alabama at Birmingham. Thus, the RELIVE
donors are less ethnically diverse than current donors.
Donor HRQOL profile
Donors’ SF-36 profile scores are shown in Figure 2. Donors
reported significantly better function andwell-being relative
to the US adult population in all domains (Table 2,
p< 0.0001 all). Overall physical and mental health were
also higher (PCS scores, 51 9, p< 0.0001; MCS scores,
539, p< 0.0001). Compared to expected SF-36 profiles
for people of their own sex and age, donors’ scores were
significantly higher (p<0.0001, for all). Between 80% and
87% of donors’ domain scores and 84% of their MCS and
PCS values were in the average or above average range for
their sex and age (Table 2).
The HRQOL profiles of White and African-American donors
are shown in Figure 3. The 95% confidence intervals (CIs)
for bothWhite and African-American donors either included
or exceeded US norms. White donors reported higher
levels of social functioning than African-American donors
(p¼0.0007); there were no other differences. Norms for
people aged 55–64 are five points lower (worse health) on
the PCS (unadjusted) than norms for those aged 35–44, yet
these donors (current mean age 58) reported higher PCS
values than the younger US population (1998 US census
population: 51% women, mean age 35 years).
Comparisons to other US populations
Donor SF-36 scores are shown at the bottom of Figure 3,
along with results from the NHMS and the AAHP (17,19).
Most NHMS profile scores are higher than the SF-36
norms. Despite this, donors’ profiles compared favorably
with NHMS results. Donors’ PCS,MCS and scores on 7 of 8
Gross et al
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Table 1: Characteristics of donors, overall and grouped by self-reported race
All donors
(n¼2455)
White or European
American (n¼2282)
Race Black or
African-American
(n¼113)
Other or unknown
(n¼60)
M (SD) M (SD) M (SD) M (SD)
Age at donation 41 (11) 41 (11) 36 (11) 38 (11)
Age at survey 58 (11) 58 (11) 52 (10) 53 (12)
Years since donation 17 (10) 17 (10) 15 (8) 15 (8)
BMI at donation 26 (5) 26 (5) 27 (5) 26 (4)
N (%) N (%) N (%) N (%)
Female 1505 (61) 1403 (61) 71 (63) 31 (52)
Hispanic/Latino 31 (1) 18 (1) 0 (0) 13 (22)
Relationship of donor to recipient
Parent 450 (18) 422 (18) 17 (15) 11 (18)
Child 316 (13) 283 (12) 21 (19) 12 (20)
Sibling 1011 (41) 942 (41) 50 (44) 19 (32)
Other relative 130 (5) 116 (5) 9 (8) 5 (8)
Spouse 219 (9) 208 (9) 8 (7) 3 (5)
Friend 173 (7) 165 (7) 4 (4) 4 (7)
Other unrelated 149 (6) 140 (6) 3 (3) 6 (10)
Missing 7 (0) 6 (0) 1 (1) 0 (0)
BMI at donation
Less than 25 1092 (44) 1021 (45) 42 (37) 29 (48)
25–29.9 883 (36) 823 (36) 42 (37) 18 (30)
30–34.9 329 (13) 296 (13) 21 (19) 12 (20)
35 or higher 102 (4) 95 (4) 6 (5) 1 (2)
Missing 49 (2) 47 (2) 2 (2) 0 (0)
Type of surgical procedure
Open 1630 (66) 1514 (66) 81 (72) 35 (58)
Laparoscopic 822 (33) 765 (34) 32 (28) 25 (42)
Unknown 3 (0) 3 (0) 0 (0) 0 (0)
Educational attainment at survey
Less than high school 66 (3) 59 (3) 5 (4) 2 (3)
High school 497 (20) 468 (21) 16 (14) 13 (22)
Some college or tech school 920 (37) 846 (37) 50 (44) 24 (40)
College degree 510 (21) 477 (21) 22 (19) 11 (18)
Graduate degree 449 (18) 421 (18) 20 (18) 8 (13)
Missing 13 (1) 11 (0) 0 (0) 2 (3)
Marital status at survey
Married or living together 1852 (75) 1750 (77) 63 (56) 39 (65)
Separated, divorced or widowed 449 (18) 408 (18) 30 (27) 11 (18)
Never married 141 (6) 113 (5) 20 (18) 8 (13)
Missing 13 (1) 11 (0) 0 (0) 2 (3)
Employment at survey
Working full-time 1272 (52) 1181 (52) 67 (59) 24 (40)
Working part-time 299 (12) 280 (12) 7 (6) 12 (20)
Not working for pay 770 (31) 729 (32) 27 (24) 14 (23)
Unemployed 80 (3) 63 (3) 10 (9) 7 (12)
Missing 34 (1) 29 (1) 2 (2) 3 (5)
Transplant center
Mayo Clinic 773 (31) 748 (33) 6 (5) 19 (32)
University of Alabama 544 (22) 442 (19) 92 (81) 10 (17)
University of Minnesota 1138 (46) 1092 (48) 15 (13) 31 (52)
Recipient vital status (according to donor)
Alive 1467 (60) 1368 (60) 67 (59) 32 (53)
Deceased 952 (39) 882 (39) 46 (41) 24 (40)
Unknown or missing 36 (1) 32 (1) 0 (0) 4 (7)
Recipient graft status (according to donor)
Functioning 1060 (43) 997 (44) 41 (36) 22 (37)
Functioning, but with problems 98 (4) 87 (4) 7 (6) 4 (7)
Not functioning 307 (13) 283 (12) 19 (17) 5 (8)
Unknown or missing 990 (40) 915 (40) 46 (41) 29 (48)
Significant differences between White and African-American donors, p<0.01. Eight donors were missing information about ethnicity.
Individuals not working for pay include homemakers, seasonal workers, retirees and students.
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domains were significantly higher or not different than
NHMS results, and when the NHMS mental health score
was higher, the difference was less than 1.2 points, below
the SF-36 threshold for a clinically meaningful difference.
HRQOL reports from African-American donors compared
favorably to AAHP results, with donors reporting better
general health perceptions (p< 0.0001), and no other
differences.
Time from donation and HRQOL
Sex- and age-adjusted PCS and MCS scores are depicted
against time from donation in Figure 4. In general, the most
recent donors reported the highest PCS, while donors
furthest away from donation reported the lowest scores.
PCS declined by half a point with each decade after
donation (slope [SE]¼0.54 [0.18] per decade,
p¼ 0.0027). For comparison, a change in the PCS score
from 51 (mean of this sample) to 50.5 (drop of half a point)
represents moving from the 47th to the 45th percentile
score in the US general population. There was not a
statistically significant decline in MCS over time at the 0.01
level (slope [SE]¼0.32 [0.15] per decade, p¼ 0.03).
White donors’ PCS scores were three points higher than
non-White donors’ (beta [SE]¼3.02 [0.85], p¼0.0004), the
threshold for a minimally important difference (16). This
difference did not change over time (race by time
interaction, p¼ 0.11). Race did not influence the trajectory
of MCS scores over time (beta [SE]¼ 1.31 [0.81], p¼ 0.11).
Procedure (laparoscopic vs. open) did not influence the
trajectory of either PCS (p¼0.31) or MCS (p¼0.73) scores
over time.
Donor self-rated health status
When donors were asked to rate their current health, the
common responseswere good (31.3%), very good (44.2%)
or excellent (18.5%). Few donors selected fair (5.2%) or
PF RP RE BP VT MH SF GH PCS MCS
0
10
20
30
40
50
60
70
80
SF-36 Health Survey Profile
Figure 2: SF-36 profile of RELIVEdonors.Boxplots display donor
scores for all the scales in the Short Form-36 Health Survey (SF-36)
profile. Higher scores indicate better health states. All SF-36 scales
are standardized to have a mean of 50 and standard deviation of 10
in the US general population. A dotted line indicates the population
mean on the y-axis. Boxes extend from the 25th to 75th
percentiles; whiskers (vertical lines) extend from the 1st to the
99th percentiles. Physical component summary (PCS) score,
mental component summary score (MCS), physical functioning
(PF), impact of physical health on role functioning at home and at
work (RP), bodily pain (BP), vitality (VT), general health perceptions
(GH), social functioning (SF), impact of mental health on role
functioning (RE) and mental health (MH).
Table 2: RELIVE donors’ Short Form-36 Health Survey (SF-36) profile and distribution of scores relative to US norms
SF-36 scores
Percent of donors with above or below average scores
based on their sex and age (in 10-year categories)
Scale Mean1,2 SD
Below average
(>5 points below), %
Average
(within 5 points), %
Above average
(>5 point above), %
PCS (N¼2415) 51 9 16 28 56
MCS (N¼2415) 53 9 16 37 47
PF (N¼2450) 51 9 14 29 57
RP (N¼2433) 52 9 14 23 63
BP (N¼2435) 52 10 20 30 50
GH (N¼2437) 53 9 15 32 54
VT (N¼2439) 53 9 19 31 49
SF (N¼2441) 52 9 14 19 68
RE (N¼2434) 52 8 13 26 61
MH (N¼2439) 53 9 17 33 50
Physical component summary (PCS) score and mental component summary (MCS) score, physical functioning (PF), impact of physical
health on role functioning at home and at work (RP), bodily pain (BP), general health perceptions (GH), vitality (VT), social functioning (SF),
impact of mental health on role functioning (RE) and mental health (MH).
1Scores were transformed to have a mean of 50 and standard deviation of 10 in the general US population. Higher scores indicate better
health states for all scales. All donormeans are significantly different fromSF-36 version 2 norms for the US general population: one-sample
t-tests, p-values <0.0001, all.
2N¼between 2415 for PCS and MCS and 2450 for PF. Missing values ranged from 5 (for PF) to 40 (for MCS and PCS).
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poor (1%). Reports of fair or poor health are more common
in the US population, 12.1% and 3.4%, respectively (19).
Figure 5 shows the proportions of RELIVE donors with
excellent or very good self-rated health by race and
education (used here as a surrogate for socioeconomic
status), and comparable rates for US White and African-
American adults. After adjustment for education, White
donors remained more likely to report excellent or very
good health than either African-American donors
(p¼0.0034) or donors of other races (p¼0.0004). Educa-
tion was strongly correlated with self-rated health among
US adults, White donors and donors of other or unknown
race, but not among African-American donors.
Most donors reported that donation had no impact on their
general health (73%). The remaining donors reported very
positive (10%), somewhat positive (6%), somewhat nega-
tive (10%) or very negative (1%) impacts. Perceived impact
of donation on health was related to race and to self-rated
health (p< 0.0001, both). Donors of other or unknown race
perceived a very negative health impact more often than
White or African-American donors (6.8% vs. 0.8% and
2.7%, respectively). Despite perceiving a very negative
impact of donation on their health, these donors rated their
current health as reasonably good: excellent (4%), very
good (8%), good (52%), fair (20%) or poor (12%), with
missing data for one donor. In response to questions about
their donation experience, about half (n¼ 11 of 25) reported
medical complications and/or emotional, psychological or
substance abuse difficulties as a result of donation, and five
reported that they never recovered from donor surgery. The
others (14 of 25) did not report these problems; they
resumed usual daily activities (e.g. driving, shopping for
groceries) less than 3 months after donor surgery, and
reported nomedical complications or emotional, psycholog-
ical or substance abuse difficulties as a result of donation.
Figure 3: SF-36 profiles of RELIVEWhite and African-American donors.Mean unadjusted Short Form-36 Health Survey (SF-36) scores
of White and African-American donors are shown as bars. Race data were obtained by self-report. The horizontal solid line marks the
population norm, and dotted lines mark0.5 SD (the range for average scores). White donors had higher scores for social functioning than
African-American donors (p¼0.0007); other SF-36 scores were not significantly different at p¼0.01. Mean scores for RELIVE donors and
two comparison groups are presented below the chart. Results from the National Health Measurement Survey (NHMS), a representative
telephone survey of US adults 35–89 years old conducted in 2005–2006 (19), are shown in the first line. RELIVE donors’ (all races combined)
SF-36 scores were significantly higher than NHMS results for the PCS, role physical, bodily pain, general health perceptions and social
functioning (p’s from 0.006 to <0.0001); scores for physical functioning, vitality, role emotional, and the MCS did not differ; and NHMS
mental health results were higher than RELIVE donors’ scores (p<0.0001). Results from the African-American Health Project (AAHP), a
population-based, in-home survey of 998African-American adults aged 49–65 living inMissouri conducted 2000–2001 (17), are shown in the
bottom line beneath the chart. SF-36 overall and domain scores of African-American donors and AAHP participants were not significantly
different, except for general health perceptions, where African-American donors reported higher scores (p<0.0001).
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Figure 4: Sex- and age-adjusted PCS and MCS scores of RELIVE donors by time from donor surgery. Each donor’s sex- and age-
adjusted physical and mental component summary (PCS and MCS) score is plotted by time from donor surgery in years in this scatterplot.
Data points above the normmean (50) on the y-axis indicate donors with better health and functioning than peers of the same age and sex.
The solid line is a loess curve fitted to the observed median score, and the dotted lines follow the 5th and 95th percentiles at each point in
time. The overall adjusted PCS and MCS scores are 549 (range 13–78) and 529 (range 3–71), respectively. RELIVE, Renal and Lung
Living Donors Evaluation Study.
Figure 5: Proportions of donors reporting ‘‘excellent’’ or ‘‘very good’’ health, according to race and education and comparable
data for USWhite and African-American adults. Bar heights indicate the proportion of donors reporting excellent or good health within
four categories of educational attainment: less than high school, high school graduate, some college or 4-year college graduate. Vertical lines
atop the bars indicate 1 standard error. The last eight bars are comparable data on self-reported health by educational attainment for US
White and African-American adults aged 25–74 from the 2005 to 2007 Behavioral Risk Factor Surveillance Systems as reported by
Braveman et al (24). Standard errors are not provided for the US population estimates because they have beenweighted to reflect the entire
population. Sixteen donorswithmissing values for education or self-rated health statuswere omitted. After adjustment for education,White
donorsweremore likely to report excellent or very good health than either African-American donors or donors of other races (p¼0.0034 and
p¼0.0004, respectively). Overall, patterns of self-rated health status are similar for donors and US adults.
Gross et al
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Predictors of impaired HRQOL
Nine percent of donors (n¼ 211) had significantly impaired
physical HRQOL, scoring more than 10 points below their
sex-by-age adjusted PCS norm (see Table S2). These
individuals would typically be unable to do vigorous activity,
have difficulty working and/or have pain or other chronic
conditions. Nine percent of donors (n¼ 233) had signifi-
cantly impaired mental HRQOL based on the MCS. These
individuals would typically have depressed or anxious
moods some or most of the time, impacting their ability
to socialize and function at work or home.
Predonation obesity, history of psychiatric difficulties and
race were independent risk factors for impaired physical
HRQOL, after adjustment for time since donation (Table 3).
The influence of excess body weight is supported by
evidence of a dose–response relationship. Donors with a
BMI of 35 or higher at time of donation had more than four
times the risk (OR¼ 4.32), donors with a BMI of 30–34.9
had nearly triple the risk (OR¼ 2.85), and donorswith a BMI
of 25–29.9 had almost double the risk (OR¼ 1.84) of
impaired physical HRQOL compared to other donors.
History of psychiatric difficulties predonation more than
doubled (OR¼ 2.46) the risk of being in the impaired group.
Non-White donors were also about twice as likely (OR
¼ 2.05) to be in the impaired group. Although the likelihood
of impaired physical HRQOLwas associated with race, this
risk was stable over time from donation. On the other hand,
higher educational attainment at time of donation and first-
degree relationship to the recipient were independent
protective factors. For each additional level of education,
the odds of having significant physical HRQOL impairment
decreased by about 25% (OR¼0.77). First-degree relatives
were half as likely as more distant relations or unrelated
donors to have significant physical HRQOL impairment.
After adjustment for the factors listed above, the following
aspects of the donation experience were associated with
increased risk of impaired physical HRQOL: estimated time
to recover from surgery, longer than expected recovery
time, longer time to resumption of usual activities, feeling
depressed or ignored andmedical or psychological difficulty
after donation. With each increment of time to resumption
of usual activities, the adjusted risk of impaired physical
HRQOL increased threefold (OR¼ 3.05). Perceptions of
strong support from health providers, family and friends
throughout the donation process were protective. Donors
who reported positive impacts of donation on their health
were also less likely to have impaired physical HRQOL.
History of psychiatric difficulties prior to donationmore than
tripled the risk of impaired mental HRQOL (OR¼ 3.82),
after adjustment for time (Table 3). Being older at time of
donation and having more education were protective. After
adjustment for these predictors, increased risk of impaired
mental HRQOLwas associatedwith: time to recovery from
surgery, time to resumption of usual activities, feeling
depressed or ignored andmedical or psychological difficulty
after donation. Factors associated with reduced risk were
positive perceptions of the donation experience, support
from health providers, family and friends, comfort with
decision to donate, positive impacts of donation on health
and current education and marital status. Factors not
associated with impaired HRQOL are listed in Table S4.
Discussion
The kidney donors in the present study reported better
physical and mental functioning and well-being than their
counterparts in the general US population. With a larger
sample and longer-term follow-up (average 17 years),
these results confirm and extend earlier reports from
single-center series (5,8,21) and recent international stud-
ies (7,9). Worldwide, about 27000 living kidney donations
are performed each year (22). In Norway, Mjoen et al (9)
surveyed 1414 donors who were on average 12.6 years
from donation. These donors reported better HRQOL on all
SF-36 domains compared to a population-based sample of
adult Norwegians. An international collaborative (7) com-
pared the HRQOL of nondonor controls to donors (N¼ 203)
whowere on average 5.5 years from donation and found no
differences in SF-36 scores.
This study presents new information on the outcomes of
African-American kidney donors. African-American donors’
SF-36 scores compared favorably to norms and results from
a population-based sample of African-American adults (17),
and were generally similar to White donors’ scores. After
adjustment for age and sex,White donors had better overall
physical functioning than non-White donors, but trends
over time from donation did not differ by race, indicating
that non-White donors did not have an accelerated decline
in function or well-being in the decades following donation
compared to White donors. These findings are reassuring,
given evidence from administrative databases that African-
American and Hispanic donors have higher risks of
developing hypertension, diabetes and chronic kidney
disease after donation than White donors, although not
higher rates than minority nondonors (23).
It has been shown that differences in self-rated health are
closely linked to socioeconomic status (24), and therefore,
we expected donors with greater educational attainments
to rate their current health higher than those with less
education. This was true for White donors, but not for
African-American donors. Reasons for this are unknown,
but we are mindful that the majority of the RELIVE African-
American donors hail from a single center and may differ
from African-American donors elsewhere in ways we were
unable to assess.
A novel finding from our work is the long-term HRQOL
impact of excess body weight in otherwise healthy adults.
We did not have current BMI information, and could not
determine if donor BMIs increasedor decreased in the years
HRQOL of Kidney Donors
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sincedonation, butobesity at timeof donation increased risk
of significant physical impairment (PCS) between 5 and
48 years later. The credibility of this finding is supported by a
graded relationship: the higher the BMI category, the
greater the risk. When BMI and the SF-36 are measured
concurrently, worse physical HRQOL (PCS) is consistently
reportedby the obese and overweight, compared to those in
the normalweight range (25,26). Bodily pain andmobility are
Table 3: Multivariable logistic regressions predicting significantly impaired physical HRQOL1 and mental HRQOL2
Physical HRQOL impairment
(n¼211 out of 2455)
Mental HRQOL impairment
(n¼233 out of 2455)
OR 95% CI p-Value OR 95% CI p-Value
(1) Model based on predonation characteristics
Age at donation, per 10 years3 – – – 0.74 (0.65, 0.86) <0.0001
10 years after donation3,4 4.38 –  2.86 – 
20 years after donation3,4 11.30 – – 5.47 – –
30 years after donation3,4 17.14 – – 6.97 – –
40 years after donation3,4 15.29 – – 5.92 – –
Non-White (ref: White) 2.05 (1.27, 3.30) 0.0034 – – –
First-degree relative of recipient (ref: extended
relation or not related)
0.54 (0.36, 0.80) 0.0025 – – –
BMI 25–29.9 (ref: <25)4 1.84 (1.31, 2.65) 0.0005 – – –
BMI 30–34.9 (ref: <25)4 2.85 (1.84, 4.42) <0.0001 – – –
BMI 35 (ref: <25)4 4.32 (2.37, 7.87) <0.0001 – – –
Education at donation (continuous, 5 levels)4 0.77 (0.64, 0.91) 0.0027 0.81 (0.70, 0.95) 0.0092
History of psychiatric difficulties prior to donation
(ref: no history or unknown)3,4,5
2.46 (1.57, 3.84) <0.0001 3.82 (2.61, 5.60) <0.0001
Model 1 plus the following, entered one at a time
Overall donation experience (poorexcellent) 0.79 (0.68, 0.92) 0.0024 0.67 (0.59, 0.77) <0.0001
Recovery time compared with expected
(shorter longer)
1.26 (1.10, 1.44) 0.0008 – – –
Overall recovery time (<3 monthsnever) 1.63 (1.31, 2.02) <0.0001 1.87 (1.53, 2.28) <0.0001
Recovery time for daily activities (<3
monthsnever)3,4
3.05 (2.26, 4.12) <0.0001 2.81 (2.11, 3.75) <0.0001
I felt depressed for a while after the surgery 1.38 (1.22, 1.56) <0.0001 1.49 (1.33, 1.67) <0.0001
Once surgery was over, no one paid attention 1.31 (1.15, 1.49) <0.0001 1.51 (1.34, 1.69) <0.0001
There was support available to me from the
healthcare providers
0.80 (0.71, 0.89) 0.0001 0.72 (0.65, 0.80) <0.0001
My family or friends supported me throughout the
donor surgery
0.78 (0.67, 0.90) 0.0007 0.69 (0.61, 0.79) <0.0001
Comfort now with the decision to donate – – – 0.64 (0.52, 0.78) <0.0001
Self-reported complication (ref: no, unknown) 1.92 (1.39, 2.64) <0.0001 2.26 (1.68, 3.03) <0.0001
How did your donation affect your general health?
(Very negatively very positively)3
0.68 (0.55, 0.84) 0.0002 0.52 (0.42, 0.64) <0.0001
Married or partnered at questionnaire completion – – – 0.64 (0.47, 0.86) 0.0032
Educational attainment at questionnaire
completion3
– – – 0.60 (0.48, 0.76) <0.0001
HRQOL, health-related quality of life; MCS, mental component summary; PCS, physical component summary.
Data were missing for less than 5% of donors for all variables except educational attainment at donation (missing for 19%); missing values
were multiply imputed using the sequential regression imputation method.
1Significantly impaired physical HRQOL was defined as a PCS >1 SD below sex-by-age norms (n¼211 out of 2455) 9% of the sample.
2Significantly impaired mental HRQOL was defined as an MCS >1 SD below sex-by-age norms (n¼233 of 2455) 9% of the sample.
3These variables remained significant (p<0.01)when all variables in this tablewere simultaneously included in themental HRQOLmodel (c-
statistic¼0.760). Mental HRQOL base model c-statistic¼0.660. Additional model c-statistics for mental HRQOL with covariates
were¼0.670–0.705.
4These variables remained significant (p<0.01) when all variables in this table were simultaneously included in the physical HRQOLmodel
(c-statistic¼0.762). BaseModel Physical HRQOLc-statistic¼0.704. Additionalmodel c-statistics for Physical HRQOLwith covariateswere
0.715–0.741.
5History of psychiatric difficulties was ascertained from medical records from the time of donation and included mentions of depression,
anxiety, bipolar disorder, posttraumatic stress disorder and other psychiatric diagnoses.

Physical HRQOL: time since donation, p<0.0001; time since donation squared, p¼0.0010.

Mental HRQOL: time since donation, p¼0.0003; time since donation squared, p¼0.0095.
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most often negatively affected by obesity. The relationship
between weight and mental HRQOL is more nuanced.
Longitudinal cohort studies and weight loss trials generally
find that gaining weight diminishes physical HRQOL, and
losing weight improves both physical and mental HRQOL.
Our findings for overweight and obese donors may have
important implications for the future HRQOL of all adults
who are currently overweight, but otherwise healthy (e.g.
have no major comorbidities).
The association of predonation obesity (BMIs>30) with
adverse long-term HRQOL is also notable in light of recent
trends to accept heavier donors in the United States.
Although the proportion of very obese donors (BMIs> 35)
changed little between 1999 and 2009 (from 2% to 3.1%),
the proportion of obese donors (BMIs> 30–35) more than
doubled (from 8% to 21.8%) during this interval (3).
Increased follow-up and study of these donors is
warranted. Our findings also add support to current
practices of excluding very obese donors, given higher
surgical complication rates, the natural history of metabolic
syndrome and recent evidence of poor long-term medical
outcomes (14). Nogueira et al (14) found 42% of obese
kidney donors (N¼ 36, average 7 years postdonation) were
hypertensive and 47% had compromised renal function.
Donor experience of long recovery time, complications and
low donor support and attention were associated with
impaired function and well-being many years after dona-
tion. These associations suggest that initiatives to improve
the donor experience should be seriously considered.
In the past, it has been difficult to identify robust predictors
of poor HRQOL among donors (5), and center differences,
small sample sizes and limited follow-up have been
identified as contributing to this problem. Varying defi-
nitions of HRQOL may also contribute, as we found
differences in the predonation factors that predicted
physical versus mental HRQOL impairment. Notably,
obesity and non-White race were risk factors specifically
for impaired physical HRQOL and older age at donationwas
specifically associatedwith reduced risk of impairedmental
HRQOL. Donor history of psychiatric difficulties (donor
chart documentation of history or treatment for depression,
anxiety, posttraumatic stress disorder or other disorders),
which has been regularly identified as a risk factor for poor
outcomes (5,27,28), was a risk factor for both poor physical
and mental HRQOL in our sample.
The main strength of RELIVE is its size, multi-center
collaboration and length of follow-up. Limitations include
the absence of predonation HRQOL data, and substantial
under-representation of minority donors. Although 9.6% of
donors in our study eligibility window were African-
American, proportionately fewer African-Americans than
White donors responded to study contacts, and as a result,
African-Americans comprised only 5%of the RELIVE donor
sample. Fewer than 2% of the donors in our eligibility
window were Hispanic or Latino, and these donors were
also less likely than White donors to respond to study
contacts. In retrospect, greater efforts should have been
made to devise more effective approaches for contacting
minority donors. Overall, only 50% of the donors whose
surgeries were identified from medical records responded
to study contact attempts. No current contact information
was available for over 900 donors, despite use of a fee-
based Internet search service to locate current addresses
and phone numbers. These limitations reflect the ambitious
nature of securing follow-up as long as 50 years after
donation. Finally, it should be kept in mind that RELIVE
donors are from three centers, and are not a representative
national sample.
A number of factors, in addition to race, differed between
donors who did and did not participate in RELIVE, including
age, education, time from donation and relationship to the
recipient. Because our primary HRQOL results were age-
adjusted and effects of all these factors were estimated in
multivariate analyses, we do not believe that these factors
served to bias our findings.
In conclusion, the majority of living kidney donors maintain
average or above average HRQOL over the long term.
Findings suggest potential donors who are overweight or
obese, less educated, have prior psychiatric difficulties, are
not White, or not first-degree relatives of the recipient
represent groups at risk for poor HRQOL. New or enhanced
efforts of predonation counseling and education, particular-
ly weight loss counseling, and postdonation monitoring
efforts could improve outcomes of these donors.
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